Evotec Had Strong H1, Foresees Dual Track Growth After Entering Biologics Space

 
• By Sten Stovall
  
Road
Evotec has expanded into high-growth biologics segment • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip